» Articles » PMID: 35848433

Screening for Subclinical Interstitial Lung Disease in Rheumatoid Arthritis Patients: Functional and Radiological Methods

Overview
Journal Turk Thorac J
Publisher Aves
Specialty Pulmonary Medicine
Date 2022 Jul 18
PMID 35848433
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Interstitial lung disease is the most frequent lung symptom of rheumatoid arthritis and is a significant contributor to morbid- ity. As a result, the target of this research was to measure the frequency of radiological and functional abnormalities in rheumatoid arthritis patients who did not have any respiratory symptoms.

Material And Methods: This study consists of 30 patients diagnosed with rheumatoid arthritis. All involved cases were exposed to entire history taking and clinical examination. All patients were examined by high-resolution computed tomography and pulmonary function tests.

Results: According to the computed tomography visual score, 73.3% showed interstitial lung disease. The most common abnormalities were reticular patterns (46.7%) followed by nodular patterns (40%) and septal lines (23.3%). However, 36% of the patients had a normal pulmonary function, while 32% had a small airway affection, 20% had restrictive lung disease, and 12% had obstructive lung disease. A significant association was found between supine expiratory volume and computed tomography visual score. Results showed no associa- tion between interstitial lung disease and all lung function test parameters.

Conclusion: Subclinical interstitial lung disease is frequent among rheumatoid arthritis patents. A combination of pulmonary func- tion tests with computed tomography is essential to enhance the recognition of subclinical interstitial lung disease as normal pulmonary function alone cannot exclude its presence.

Citing Articles

The Role of Nailfold Videocapillaroscopy in the Diagnosis and Monitoring of Interstitial Lung Disease Associated with Rheumatic Autoimmune Diseases.

Anghel D, Prioteasa O, Nicolau I, Bucurica S, Belinski D, Popescu G Diagnostics (Basel). 2025; 15(3).

PMID: 39941292 PMC: 11816486. DOI: 10.3390/diagnostics15030362.


The global prevalence of interstitial lung disease in patients with rheumatoid arthritis: a systematic review and meta-analysis.

Prasanna H, Inderjeeth C, Nossent J, Almutairi K Rheumatol Int. 2025; 45(2):34.

PMID: 39825929 PMC: 11742767. DOI: 10.1007/s00296-025-05789-4.


Pulmonary involvement in newly diagnosed and untreated rheumatoid arthritis and psoriatic arthritis: a prospective longitudinal study.

Winter L, Petzinna S, Skowasch D, Pizarro C, Weber M, Kutting D Rheumatol Int. 2024; 45(1):3.

PMID: 39692860 PMC: 11655587. DOI: 10.1007/s00296-024-05751-w.

References
1.
Sparks J, He X, Huang J, Fletcher E, Zaccardelli A, Friedlander H . Rheumatoid Arthritis Disease Activity Predicting Incident Clinically Apparent Rheumatoid Arthritis-Associated Interstitial Lung Disease: A Prospective Cohort Study. Arthritis Rheumatol. 2019; 71(9):1472-1482. PMC: 6716994. DOI: 10.1002/art.40904. View

2.
Hoffman E, Ahmed F, Baumhauer H, Budoff M, Carr J, Kronmal R . Variation in the percent of emphysema-like lung in a healthy, nonsmoking multiethnic sample. The MESA lung study. Ann Am Thorac Soc. 2014; 11(6):898-907. PMC: 4213995. DOI: 10.1513/AnnalsATS.201310-364OC. View

3.
Bitterman P, Rennard S, Keogh B, Wewers M, Adelberg S, Crystal R . Familial idiopathic pulmonary fibrosis. Evidence of lung inflammation in unaffected family members. N Engl J Med. 1986; 314(21):1343-7. DOI: 10.1056/NEJM198605223142103. View

4.
Wilsher M, Voight L, Milne D, Teh M, Good N, Kolbe J . Prevalence of airway and parenchymal abnormalities in newly diagnosed rheumatoid arthritis. Respir Med. 2012; 106(10):1441-6. DOI: 10.1016/j.rmed.2012.06.020. View

5.
Gochuico B, Avila N, Chow C, Novero L, Wu H, Ren P . Progressive preclinical interstitial lung disease in rheumatoid arthritis. Arch Intern Med. 2008; 168(2):159-66. DOI: 10.1001/archinternmed.2007.59. View